Top Pharmaceutical Preparations Stocks by Roiver Score™
The 100 Pharmaceutical Preparations companies we cover, ranked by the Roiver Score — a transparent 0–100 quality composite. Novo-Nordisk A/S leads with a score of 87.
| # | Company | Market cap | Score |
|---|---|---|---|
| 1 | NVONovo-Nordisk A/S | $176.5B | 87Excellent |
| 2 | INVAInnoviva, Inc. Common Stock | $1.5B | 78Excellent |
| 3 | PLRXPliant Therapeutics, Inc. Common Stock | $53M | 75Excellent |
| 4 | RIGLRigel Pharmaceuticals Inc. (New) | $958M | 75Excellent |
| 5 | CRMDCorMedix Inc. | $444M | 75Excellent |
| 6 | KROSKeros Therapeutics, Inc. Common Stock | $219M | 75Excellent |
| 7 | ZTSZOETIS INC. | $32.9B | 71Solid |
| 8 | JNJJohnson & Johnson | $657.7B | 69Solid |
| 9 | GMABGenmab A/S ADS | $35.1B | 67Solid |
| 10 | NVSNovartis AG | $305.6B | 67Solid |
| 11 | SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share) | $106.2B | 65Solid |
| 12 | REGNRegeneron Pharmaceuticals Inc | $95.5B | 65Solid |
| 13 | HRMYHarmony Biosciences Holdings, Inc. Common Stock | $2.3B | 65Solid |
| 14 | GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | $99.2B | 64Solid |
| 15 | MRKMerck & Co., Inc. | $368.9B | 64Solid |
| 16 | FBIOFortress Biotech, Inc. | $64M | 63Solid |
| 17 | COLLCollegium Pharmaceutical, Inc. Common Stock | $775M | 63Solid |
| 18 | UTHRUnited Therapeutics Corp | $25.7B | 60Solid |
| 19 | PBYIPUMA BIOTECHNOLOGY INC | $539M | 60Solid |
| 20 | ADXNAddex Therapeutics Ltd American Depositary Shares | $5M | 60Solid |
| 21 | HCMHUTCHMED (China) Limited American Depositary Shares | $2.3B | 60Solid |
| 22 | PTCTPTC Therapeutics, Inc. | $5.0B | 60Solid |
| 23 | MCRBSeres Therapeutics, Inc. | $18M | 60Solid |
| 24 | ZVRAZevra Therapeutics, Inc. Common Stock | $610M | 59Solid |
| 25 | SIGASIGA Technologies Inc. | $218M | 58Solid |
| 26 | AZNAstraZeneca PLC | $289.5B | 58Solid |
| 27 | ACADAcadia Pharmaceuticals Inc. | $3.5B | 56Solid |
| 28 | PBHPrestige Consumer Healthcare Inc. | $2.3B | 55Solid |
| 29 | RDYDr. Reddy's Laboratories Limited American Depositary Shares | $11.8B | 55Solid |
| 30 | VRTXVertex Pharmaceuticals Inc | $141.7B | 53Solid |
| 31 | ABTAbbott Laboratories | $183.8B | 53Solid |
| 32 | AMPHAmphastar Pharmaceuticals, Inc. | $1.2B | 52Solid |
| 33 | EBSEmergent Biosolutions, Inc. | $349M | 52Solid |
| 34 | CORTCorcept Therapeutics Inc. | $8.8B | 52Solid |
| 35 | QTTBQ32 Bio Inc. Common Stock | $265M | 50Solid |
| 36 | MREOMereo BioPharma Group plc American Depositary Shares | $46M | 50Solid |
| 37 | MNOVMedicinova, Inc. | $69M | 50Solid |
| 38 | PAHCPhibro Animal Health Corporation Class A | $1.6B | 50Solid |
| 39 | ALKSAlkermes Inc. plc | $7.6B | 49Mixed |
| 40 | BMYBristol-Myers Squibb Co. | $127.6B | 47Mixed |
| 41 | ANIPANI Pharmaceuticals, Inc. | $1.7B | 46Mixed |
| 42 | TGTXTG Therapeutics, Inc. | $9.4B | 44Mixed |
| 43 | TRAWTraws Pharma, Inc. Common Stock | $5M | 40Mixed |
| 44 | PFEPfizer Inc. | $174.0B | 39Mixed |
| 45 | BMRNBioMarin Pharmaceuticals Inc | $11.3B | 38Mixed |
| 46 | LFVNLifevantage Corporation Common Stock (Delaware) | $74M | 37Mixed |
| 47 | CYRXCryoPort, Inc. Common Stock | $876M | 34Mixed |
| 48 | ALNYAlnylam Pharmaceuticals, Inc. | $22.1B | 34Mixed |
| 49 | ONCBeOne Medicines Ltd. American Depositary Shares | $41.9B | 34Mixed |
| 50 | ORGOOrganogenesis Holdings Inc. Class A Common Stock | $99M | 34Mixed |
| 51 | KMDAKamada Ltd | $444M | 34Mixed |
| 52 | LLYEli Lilly & Co. | $1.3T | 33Mixed |
| 53 | IRWDIronwood Pharmaceuticals, Inc. - Class A | $578M | 33Mixed |
| 54 | TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | $66.8B | 33Mixed |
| 55 | ABBVABBVIE INC. | $521.1B | 33Mixed |
| 56 | NATRNature's Sunshine Products Inc. | $216M | 32Mixed |
| 57 | PCRXPacira BioSciences, Inc. Common Stock | $1.5B | 31Mixed |
| 58 | OGNOrganon & Co. | $3.6B | 30Mixed |
| 59 | JAZZJazz Pharmaceuticals, Inc. | $14.0B | 29Mixed |
| 60 | PHARPharming Group N.V. ADS, each representing 10 ordinary shares | $866M | 29Mixed |
| 61 | AKBAAkebia Therapeutics, Inc. | $196M | 26Mixed |
| 62 | INDVIndivior Pharmaceuticals, Inc. Common Stock | $4.2B | 26Mixed |
| 63 | KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $7.2B | 26Mixed |
| 64 | LGNDLigand Pharmaceuticals Inc. | $6.4B | 26Mixed |
| 65 | ZYBTZhengye Biotechnology Holding Limited Class A Ordinary Shares | $62M | 26Mixed |
| 66 | APLMWApollomics Inc. Warrant | $1M | 25Mixed |
| 67 | SPRBSpruce Biosciences, Inc. Common Stock | $133M | 25Mixed |
| 68 | IRONDisc Medicine, Inc. Common Stock | $3.6B | 25Mixed |
| 69 | PTGXProtagonist Therapeutics, Inc | $9.4B | 25Mixed |
| 70 | VERAVera Therapeutics, Inc. Class A Common Stock | $2.2B | 25Mixed |
| 71 | ANROAlto Neuroscience Inc. | $887M | 25Mixed |
| 72 | BDRXBiodexa Pharmaceuticals plc American Depositary Shs | $945068 | 25Mixed |
| 73 | GANXGain Therapeutics, Inc. Common Stock | $49M | 25Mixed |
| 74 | CATXPerspective Therapeutics, Inc. | $131M | 25Mixed |
| 75 | SVRASavara Inc. | $990M | 25Mixed |
| 76 | DYNDyne Therapeutics, Inc. Common Stock | $3.1B | 25Mixed |
| 77 | SEPNSepterna, Inc. Common Stock | $2.1B | 25Mixed |
| 78 | GHRSGH Research PLC Ordinary Shares | $1.4B | 25Mixed |
| 79 | SXTCChina SXT Pharmaceuticals, Inc. Class A Ordinary Shares | $336619 | 25Mixed |
| 80 | TOVXTheriva Biologics, Inc. | $8M | 25Mixed |
| 81 | APLMApollomics Inc. Class A Ordinary Shares | $60M | 25Mixed |
| 82 | ATHEAlterity Therapeutics Limited American Depositary Shares | $39M | 25Mixed |
| 83 | MLTXMoonLake Immunotherapeutics Class A Ordinary Shares | $1.0B | 25Mixed |
| 84 | IRDOpus Genetics, Inc. Common Stock | $305M | 25Mixed |
| 85 | ALDXAldeyra Therapeutics, Inc. | $34M | 24Weak |
| 86 | COGTCogent Biosciences, Inc. Common Stock | $5.4B | 24Weak |
| 87 | STOKStoke Therapeutics, Inc. Common Stock | $1.7B | 24Weak |
| 88 | ALXOALX Oncology Holdings Inc. Common Stock | $169M | 24Weak |
| 89 | INCRIntercure Ltd. Ordinary Shares | $60M | 23Weak |
| 90 | GERNGeron Corp | $575M | 22Weak |
| 91 | VTRSViatris Inc. Common Stock | $21.9B | 21Weak |
| 92 | AYTUAYTU BioPharma, Inc. Common Stock | $21M | 21Weak |
| 93 | RMTIRockwell Medical, Inc. (DE) Common Stock | $28M | 20Weak |
| 94 | ARVNArvinas, Inc | $514M | 20Weak |
| 95 | ALTAltimmune, Inc. Common Stock | $397M | 20Weak |
| 96 | OGIOrganigram Global Inc. Common Shares | $135M | 20Weak |
| 97 | RCUSArcus Biosciences, Inc. | $2.3B | 20Weak |
| 98 | ABEOAbeona Therapeutics Inc. Common Stock | $249M | 20Weak |
| 99 | NUVBNuvation Bio Inc. | $1.7B | 20Weak |
| 100 | IGCIGC Pharma, Inc. | $19M | 20Weak |
Track pharmaceutical preparations quality
Follow these names, get weekly AI research digests, and see when their scores change.
Start free